PPS 17.01
Publiek private samenwerking tussen: VSBN, BWC Martini Ziekenhuis, Hanze Hogeschool Groningen en IntelaMetrix Inc.
Projectleider: Marianne Nieuwenhuis, VSBN & BWC Martini Ziekenhuis, Groningen

Gestart: maart 2018

Ultrasonography to assess loss of skeletal muscle mass in patients with major burns, UMBO

As well as skin loss, patients with major burns suffer from muscle loss, which compromises functioning and quality of life. We aim to make assessment of muscle loss and recovery possible and practical for patients with major burns using ultrasonography, in particular the BodyMetrix ultrasonography system.

Nowadays more patients survive more severe burns. This positive development however, is accompanied by a problem: loss of muscle, which is a major threat to functioning and quality of life of burn survivors. Given the severity of the condition, assessment of muscle status requires methods that are easy to perform by health care professionals in complex health care settings, non-invasive for the patient, and easy to clean because of high infection risk. Until now, its assessment was complex, if at all possible, in this population. Thus knowledge on loss and recovery of muscle (size and quality) is scarce which in turn hampers the development and evaluation of interventions to counteract muscle loss and support recovery, like nutrition and (early) mobilisation.

Ultrasonography does have potential to assess muscles in patients with major burns, the BodyMetrix ultrasonography system in particular, being a non-invasive, practical, cheap and accessible method to assess muscles.  With this project, we aim to make assessment of muscle mass with BodyMetrix possible, and investigate its feasibility, validity and reliability in patients with major burns. If validity and reliability are sufficient, muscle size and quality and recovery over time will be evaluated.

This project will provide us with the necessary assessment method to gain fundamental insights in the process of muscle wasting and recovery, evaluate (new) treatments, and will thus potentially contribute to improving the outcome of patients with major burns.